235 related articles for article (PubMed ID: 26845265)
21. Treatment outcomes of acute bipolar depressive episode with psychosis.
Caldieraro MA; Dufour S; Sylvia LG; Gao K; Ketter TA; Bobo WV; Walsh S; Janos J; Tohen M; Reilly-Harrington NA; McElroy SL; Shelton RC; Bowden CL; Deckersbach T; Nierenberg AA
Depress Anxiety; 2018 May; 35(5):402-410. PubMed ID: 29329498
[TBL] [Abstract][Full Text] [Related]
22. Bipolar depression and suicidal ideation: Moderators and mediators of a complex relationship.
Kamali M; Reilly-Harrington NA; Chang WC; McInnis M; McElroy SL; Ketter TA; Shelton RC; Deckersbach T; Tohen M; Kocsis JH; Calabrese JR; Gao K; Thase ME; Bowden CL; Kinrys G; Bobo WV; Brody BD; Sylvia LG; Rabideau DJ; Nierenberg AA
J Affect Disord; 2019 Dec; 259():164-172. PubMed ID: 31445343
[TBL] [Abstract][Full Text] [Related]
23. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial.
Miklowitz DJ; Otto MW; Frank E; Reilly-Harrington NA; Kogan JN; Sachs GS; Thase ME; Calabrese JR; Marangell LB; Ostacher MJ; Patel J; Thomas MR; Araga M; Gonzalez JM; Wisniewski SR
Am J Psychiatry; 2007 Sep; 164(9):1340-7. PubMed ID: 17728418
[TBL] [Abstract][Full Text] [Related]
24. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
25. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
Young AH; McElroy SL; Bauer M; Philips N; Chang W; Olausson B; Paulsson B; Brecher M;
J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
[TBL] [Abstract][Full Text] [Related]
26. Quetiapine
Berk M; Daglas R; Dandash O; Yücel M; Henry L; Hallam K; Macneil C; Hasty M; Pantelis C; Murphy BP; Kader L; Damodaran S; Wong MTH; Conus P; Ratheesh A; McGorry PD; Cotton SM
Br J Psychiatry; 2017 Jun; 210(6):413-421. PubMed ID: 28254958
[No Abstract] [Full Text] [Related]
27. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
Thase ME; Macfadden W; Weisler RH; Chang W; Paulsson B; Khan A; Calabrese JR;
J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
[TBL] [Abstract][Full Text] [Related]
28. Course and outcome in bipolar affective disorder: a longitudinal follow-up study.
Goldberg JF; Harrow M; Grossman LS
Am J Psychiatry; 1995 Mar; 152(3):379-84. PubMed ID: 7864263
[TBL] [Abstract][Full Text] [Related]
29. Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.
Kauer-Sant'Anna M; Bond DJ; Lam RW; Yatham LN
Compr Psychiatry; 2009; 50(1):1-8. PubMed ID: 19059506
[TBL] [Abstract][Full Text] [Related]
30. Patterns of changes in bipolar depressive symptoms revealed by trajectory analysis among 482 patients with bipolar disorder.
Behrendt-Møller I; Madsen T; Sørensen HJ; Sylvia L; Friedman ES; Shelton RC; Bowden CL; Calabrese JR; McElroy SL; Ketter TA; Reilly-Harrington NA; Gao K; Thase M; V Bobo W; Tohen M; McInnis M; Kamali M; Kocsis JH; Deckersbach T; Köhler-Forsberg O; Nierenberg AA
Bipolar Disord; 2019 Jun; 21(4):350-360. PubMed ID: 30383333
[TBL] [Abstract][Full Text] [Related]
31. Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with bipolar I or II disorder: results from the Bipolar CHOICE trial.
Bobo WV; Reilly-Harrington NA; Ketter TA; Brody BD; Kinrys G; Kemp DE; Shelton RC; McElroy SL; Sylvia LG; Kocsis JH; McInnis MG; Friedman ES; Singh V; Tohen M; Bowden CL; Deckersbach T; Calabrese JR; Thase ME; Nierenberg AA; Rabideau DJ; Schoenfeld DA; Faraone SV; Kamali M
J Affect Disord; 2014 Jun; 161():30-5. PubMed ID: 24751304
[TBL] [Abstract][Full Text] [Related]
32. Health-related quality of life in adolescents with bipolar I disorder.
Rademacher J; DelBello MP; Adler C; Stanford K; Strakowski SM
J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):97-103. PubMed ID: 17343557
[TBL] [Abstract][Full Text] [Related]
33. Poor quality of life and functioning in bipolar disorder.
Sylvia LG; Montana RE; Deckersbach T; Thase ME; Tohen M; Reilly-Harrington N; McInnis MG; Kocsis JH; Bowden C; Calabrese J; Gao K; Ketter T; Shelton RC; McElroy SL; Friedman ES; Rabideau DJ; Nierenberg AA
Int J Bipolar Disord; 2017 Dec; 5(1):10. PubMed ID: 28188565
[TBL] [Abstract][Full Text] [Related]
34. A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.
Moore GJ; Cortese BM; Glitz DA; Zajac-Benitez C; Quiroz JA; Uhde TW; Drevets WC; Manji HK
J Clin Psychiatry; 2009 Apr; 70(5):699-705. PubMed ID: 19389332
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal impact of a collaborative care model on employment outcomes in bipolar disorder.
Ryan KA; Eisenberg D; Kim HM; Lai Z; McInnis M; Kilbourne AM
J Affect Disord; 2015 Dec; 188():239-42. PubMed ID: 26368949
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
[TBL] [Abstract][Full Text] [Related]
38. Co-occurring conditions and health-related quality of life in patients with bipolar disorder.
Kilbourne AM; Perron BE; Mezuk B; Welsh D; Ilgen M; Bauer MS
Psychosom Med; 2009 Oct; 71(8):894-900. PubMed ID: 19661187
[TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
Suppes T; McElroy SL; Sheehan DV; Hidalgo RB; Cosgrove VE; Gwizdowski IS; Feldman NS
J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
[TBL] [Abstract][Full Text] [Related]
40. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
